Skip to main content
. 2021 Nov 9;16:14–23. doi: 10.1016/j.ejcsup.2021.06.003

Table 1.

Intervention and comparators.

Treatment Indication Regimen Price
[177Lu]Lu-DOTA-TATE (Lutathera®) GI-NETs and P-NETs 4 administrations of 7.4 GBq (200 mCi), once every 8 weeks [28] 29.6 GBq (800 mCi) = £71,500
Standard of care (SoC) GI-NETs and P-NETs 60 mg Octreotide LAR (Sandostatin®), once every 28-day cycle 30 mg vial = £998.41
Everolimus (Afinitor®) GI-NETs and P-NETs 10 mg administered once daily, until progression [6] 30-tab, 10 mg packs = £2673
Sunitinib (Sutent®) GI-NETs and P-NETs 37.5 mg administered once daily, until progression [7] 30-tab, 12.5 mg packs = £784.70

GI-NETs, neuroendocrine tumours located in the gastrointestinal tract; P-NETs, neuroendocrine tumours located in the pancreas.